G
Girdhar G. Agarwal
Researcher at University of Lucknow
Publications - 74
Citations - 1130
Girdhar G. Agarwal is an academic researcher from University of Lucknow. The author has contributed to research in topics: Population & Fibromyalgia. The author has an hindex of 17, co-authored 71 publications receiving 963 citations. Previous affiliations of Girdhar G. Agarwal include King George's Medical University.
Papers
More filters
Journal ArticleDOI
Three day versus five day treatment with amoxicillin for non-severe pneumonia in young children: a multicentre randomised controlled trial.
TL;DR: Treatment with oral amoxicillin for three days was as effective as for five days in children with non-severe pneumonia, and was associated with isolation of respiratory syncytial virus.
Journal ArticleDOI
Care-seeking behavior and out-of-pocket expenditure for sick newborns among urban poor in Lucknow, northern India: a prospective follow-up study
TL;DR: Since more than half of the neonates have morbidity and out-of-pocket expenditure on neonatal illnesses often exceeds the family income of the lower strata of the low income group in the community, there is a need to either introduce health insurance scheme or subsidize health care for them.
Journal Article
Relationship of severity of depression, anxiety and stress with severity of fibromyalgia.
TL;DR: Results suggest that FMS is associated with depression, anxiety and stress and in FMS magnitude of negative affects is significantly correlated with FIQR, however, depression alone in absence of FMS can also give rise to all three components ofFIQR.
Journal ArticleDOI
A randomized controlled trial to evaluate the slow-acting symptom modifying effects of a regimen containing colchicine in a subset of patients with osteoarthritis of the knee.
S.K. Das,K. Mishra,S. Ramakrishnan,RD Srivastava,Girdhar G. Agarwal,Ragini Singh,A.R. Sircar +6 more
TL;DR: The addition of colchicine produced significantly greater symptomatic benefit at 16 and 20 weeks than intraarticular steroid and piroxicam alone in patients with knee OA with inflammation.
Journal ArticleDOI
A randomized controlled trial to evaluate the slow-acting symptom-modifying effects of colchicine in osteoarthritis of the knee: a preliminary report.
Siddharth Kumar Das,S. Ramakrishnan,Kavita Mishra,Ragini Srivastava,Girdhar G. Agarwal,Ragini Singh,Amit Sircar +6 more
TL;DR: Among patients with OA of the knee, the group receiving colchicine plus nimesulide exhibited significantly greater symptomatic benefit at 20 weeks than did the control group receiving nimesULide plus placebo.